Outcome and Treatment of Antenatally Diagnosed Nonimmune Hydrops Fetalis

Abstract

Introduction: The objectives of this study were to evaluate the outcome of nonimmune hydrops fetalis in an attempt to identify independent predictors of perinatal mortality. Material and Methods: A retrospective cohort study was conducted including all cases of nonimmune hydrops from two tertiary care centers. Perinatal outcome was evaluated after classifying nonimmune hydrops into ten etiological groups. We examined the effect of etiology, site of fluid accumulation, and gestational age at delivery on postnatal survival. Neonatal mortality and hospital discharge survival were compared between the expectant management and fetal intervention groups among those with idiopathic etiology. Results: A total of 142 subjects were available for analysis. Generally, nonimmune hydrops carried 37% risk of neonatal mortality and 50% chance of survival to discharge, which varies markedly based on the underlying etiology. Ascites was an independent predictor of perinatal mortality (p value = 0.003). There was nonsignificant difference in neonatal mortality and hospital discharge survival among idiopathic cases that were managed expectantly versus those in whom fetal intervention was carried out. Discussion: The outcome of nonimmune hydrops varies largely according to the underlying etiology and the presence of ascites is an independent risk factor for perinatal mortality. In our series, fetal intervention did not offer survival advantage among fetuses with idiopathic nonimmune hydrops.

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review

“…For symptomatic patients, it is recommended that fetal therapy be postponed until maternal conditions stabilize and patients have recovered from the disease. Some examples of fetal surgeries that are still currently offered at Mayo Clinic include fetoscopic laser ablation of placental anastomoses for twin-to-twin transfusion syndrome, 78 in utero repair of spina bifida, 79 intrauterine fetal blood transfusion, 80 in utero intervention for lower urinary tract obstruction, 81 fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia, 82 in utero procedure for fetal tumors associated with hydrops, 83 and in utero intervention for severe congenital heart defects. 84…”

Clinical characteristics and neonatal outcomes of liveborn newborns with hydrops fetalis treated in a tertiary level neonatal intensive care unit

“…The efficacy is the lowest for idiopathic NIHF (Fukushima et al, ). In one study, there was no significant difference in perinatal mortality between fetuses with idiopathic NIHF with or without fetal intervention (Nassr et al, ). It has been reported in the literature that fetal intervention can pose a risk without any benefit and increase neonatal mortality even further (Mann, Johnson, & Wilson, ; Nassr, Ness, et al, ; Nassr, Ruano, et al, ).…”

Hydrops Fetalis

“…The long-term prognosis of survivors of NIFH also depends on underlying etiology. Following parvovirus B19 infection with fetal anemia and transfusion, there appears to be some neurological sequelae in about 30% of babies [29]. This could be a direct consequence of parvovirus infection with fetal anemia or transfusion.…”